The combined effect: a bottle that should be good for 28 days can be unsafe at day 10 if multiple failure modes stack
In March 2026 alone, global sales hit $99.5 billion - nearly double the $55.5 billion recorded in March 2025

Visual signs of degradation Injectable GHK-Cu changes: Clear to cloudy (bacterial growth or precipitation) Color change (bluish, greenish tint from copper oxidation) Particles floating in solution Separation or settling Topical serum changes: Darker color (oxidation) Layer separation Texture changes (thicker or thinner) Crystallization Powder changes: Color darkening Clumping (moisture absorption) Greenish or bluish tint Loss of fine powder consistency Smell and texture changes Off odors: Metallic smell intensifying (some metallic odor is normal for copper peptides) Sour or rancid smell (bacterial contamination or lipid oxidation in serums) Any unusual smell different from when first opened Texture issues: Serum becoming grainy Unusual thickness or thinning Sticky residue Separation that doesn't re-mix Effectiveness loss Signs of reduced potency: Reduced healing speed (injectable) Less visible skin improvement (topical) Need to use more product for same effect Complete lack of expected results When in doubt: Discard and get fresh product

Interactive effects of warming and copper toxicity on a tropical freshwater green microalga Chloromonas augustae (chlorophyceae)
Weight loss effects of GLP-1RAs Liraglutide (3.0 mg, Saxenda), a GLP-1RA that activates the GLP-1 receptor, was approved by the FDA in December 2014 for adult obesity treatment [38] and has recently shown efficacy in adolescents aged 12 to 18 years
[8] [12] [13] Nomenclature [edit] Standardized GST nomenclature first proposed in 1992 identifies the species to which the isozyme of interest belongs with a lower-case initial (e.g., "h" for human), which precedes the abbreviation GST